Shenzhen Cau Technology Company Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Cau Technology Company Limited with three other
pharmaceutical manufacturers in Asia:
Genmont Biotech Inc
sales of 552.94 million Taiwanese Dollars [US$17.94 million]
of which 69%
was Jingyue Company),
Cellumed Co Ltd
of South Korea
(21.61 billion Korean Won [US$19.15 million]
based in Taiwan
(562.74 million Taiwanese Dollars [US$18.26 million]
of which 99%
was Finished Products Sales).
During the year ended December of 2017, sales at
Shenzhen Cau Technology Company Limited were 138.61 million Chinese Renmimbi (US$20.13 million).
decrease of 50.8%
versus 2016, when the company's sales were 281.86 million Chinese Renmimbi.